Log in to your Inderes Free account to see all free content on this page.
Create account

CellaVision

125.60 SEK

-18.02 %

1,475 following

CEVI

NASDAQ Stockholm

Medical Equipment & Services

Health Care

-18.02 %
-13.97 %
-19.18 %
-20.10 %
-32.98 %
-22.66 %
-18.97 %
-64.90 %
+705.13 %

CellaVision operates in the medical technology industry and focuses on the development and manufacture of systems for digital blood analysis. The company focuses on digital cell morphology and offers innovations for analyzers, instruments, reagents and software used in hematology laboratories. The company's products are aimed at healthcare institutions and laboratories worldwide. CellaVision was founded in 1994 and is headquartered in Lund, Sweden.

Read more
Market cap
3B SEK
Turnover
35.05M SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
24.4.
2026

Interim report Q1'26

28.4.
2026

General meeting '26

29.4.
2026

Annual dividend

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.